Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
A recent article at Healio Rheumatology highlights a presentation given by Dr. Arthur Kavanaugh of the University of California to attendees at the 2022 Clinical Rheumatology Congress East. Dr. Kavanaugh…
Continue Reading
A Growing List of Options for Psoriatic Arthritis Patients
Tuberous sclerosis complex (TSC) is classified as a rare genetic disorder that causes typically benign tumors in the brain, skin, heart, kidneys, or lungs. As described in a recent article…
Continue Reading
Researchers Created Mini-Kidneys to Identify Tuberous Sclerosis Complex and Solve a Medical Mystery
According to a press release by Merck & Co. issued on June 24, the European Commission has approved the use of adjuvant Pembrolizumab to treat resected stage IIB/C melanoma. "Adjuvant"…
Continue Reading
The European Commission Has Approved Pembrolizumab (Keytruda) to Treat Resected Stage IIB and IIC Melanoma
source: pixabay.com
A study of hereditary angioedema (HAE) patients in Brazil was featured in an article in the Angioedema News. Researchers found that patients waited on average seventeen years for a…
Continue Reading
Patients in Brazil Wait Decades for a Hereditary Angioedema Diagnosis
source: pixabay.com
The history of mesothelioma dates back to 1767 as being the earliest record of tumors found on the lining of the lungs. In 1909 J.G. Adami introduced the term…
Continue Reading
Mesothelioma: A Study of T-Cell Infiltration As the Disease Evolves
source: pixabay.com
Findings from the MITO23 Trial investigating the outcome of the chemotherapy drug trabectedin against physician’s choice to treat BRCA-mutated patients with ovarian cancer were presented at ASCO’s 2022 Annual…
Continue Reading
ICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint
source: pixabay.com
The patient, age 82, had recovered from a stroke several months ago. According to a recent article reported on dnyuz.com and originally published in the New York Times, the…
Continue Reading
ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
source: pixabay.com
The most common gastrointestinal tumors in the world are esophageal cancers. A recent article in DovePress reports that the malignancy is also the eighth most common worldwide. In China…
Continue Reading
Study: Anlotinib as a Monotherapy for Esophageal Cancer
The study was intended to recruit 6,000 Alzheimer's patients, but even after recruiting had proceeded for seven months, just 29 patients were enrolled. As a result, the trial was cancelled,…
Continue Reading
Alzheimer’s Study Cancelled After 29 Patients Enrolled Rather Than the Anticipated 6000
source: pixabay.com
The novel program called BeginNGS™ was described in a recent article which has a goal of testing for five hundred disorders and several thousand infants. Rady Children's Institute for…
Continue Reading
New Program Evaluates the Adaptability of Precision Medicine to Identify Over 400 Genetic Disorders and Potential Treatments
Genetic testing has always been costly and directed at DNA sequencing. Only a limited number of genes could be tested. It was useful to a small number of patients…
Continue Reading
Improved Genetic Testing Brings a More Accurate Diagnosis of Primary Immunodeficiency Disorders
IBD (inflammatory bowel disease) is an umbrella term for ulcerative colitis and Crohn’s disease involving chronic inflammation in the digestive tract. Common symptoms are fatigue, pain, and reduction in appetite.…
Continue Reading
Study: H. Pylori in a New, Beneficial Role in Inflammatory Bowel Disease
Liver cirrhosis (scarring) can be fatal because damage to the liver is irreversible. A cirrhotic liver leads to liver failure, liver cancer, and eventually death. According to a report in…
Continue Reading
Patients with Liver Diseases Causing Cirrhosis May Be Predisposed to HCC
source: shutterstock.com
According to an article recently published in Targeted Oncology, the FDA approved olaparib (Lynparza), a product of AstraZeneca Pharmaceuticals, in March of this year. Lynparaza will be used as adjuvant…
Continue Reading
The FDA Approves Olaparib for BRCA-mutated HER2 Early Breast Cancer
source: pixabay.com
The medical term for an “informal caregiver” describes a person who willingly takes the responsibility to help a spouse, family member, friend, or partner. The level of care and responsibility…
Continue Reading
Cancer Commons Presents a Webinar Recording: You’re Not Alone—Validating the Caregiver Experience
source: pixabay.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: Your Illness is Real: How to be Seen, Heard, and Treated with Compassion
source: pixabay.com
According to a recent article in The British publication The Economic Times, a group of researchers at McMaster University have a win-win proposal for myotonic dystrophy (MD) patients. Eleven people were…
Continue Reading
12 Weeks of Exercise Increased Fitness in Myotonic Dystrophy Patients
Thanks to Amylyx Pharmaceuticals, Canada becomes the first country worldwide to have access to an ALS drug branded Albrioza (originally AMX0035). According to an article in Yahoo News, the drug…
Continue Reading
Canada Approves its Third Drug For Amyotrophic Lateral Sclerosis (ALS)
source: shutterstock.com
In normal development, genes are usually inherited in pairs - with one copy from the father and one inherited from the mother. When one copy of the TCF4 gene, which…
Continue Reading
A New Study Finds That Gene Therapy May Prevent or Reverse Pitt-Hopkins Syndrome
We have been told occasionally that certain phrases we use when speaking with a terminally ill patient may sound insensitive. We have also been told what we should not say…
Continue Reading
Do We Need a “Rule Book” to Speak With Terminally Ill Patients?
Pancreatic cancer is one of the deadliest forms of cancer. According to the American Cancer Society (ACS), only about 11% of patients are expected to survive more than five years…
Continue Reading
A Novel Treatment for Pancreatic Cancer, a Deadly Disease
Lately, the first thing that enters a person’s mind if they encounter an unusual pain is that they may have cancer. Yet that was the last thing Georgina Masson, an…
Continue Reading
They Diagnosed Tonsillitis, But it Was Actually Acute Myeloid Leukemia
Sydney Miller, born in the UK in March 2020, has an extremely rare disease. Newsweek recently carried a story about Sydney and her illness. This little girl captured the hearts…
Continue Reading
Primrose Syndrome Affects Only Fifty Children Worldwide
source: pixabay.com
Leukemia, in general terms, is a form of cancer that affects the bone marrow and blood cells. According an article in Medical News Today, leukemia is categorized in accordance…
Continue Reading
An Overview of Chronic Lymphocytic Leukemia (CLL)
The Irish Times recently featured a book by Dr. Karl Herrup about “How Not to Study a Disease." Dr. Herrup is clear that he opposes the theory that the amyloid…
Continue Reading
What Causes of Alzheimer’s? Time for a New Direction